Paper41244121
The oxidative modification of transcription factor FOXM1 by Peroxiredoxin1 facilitates DNA damage repair and cancer progression.
Li Z and 9 others. Am J Cancer Res, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. The oxidative modification of transcription factor FOXM1 by Peroxiredoxin1 facilitates DNA damage repair and cancer progression. Papers, record 41244121. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41244121
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The oxidative modification of transcription factor FOXM1 by Peroxiredoxin1 facilitates DNA damage repair and cancer progression.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28427863 | ROS in Cancer: The Burning Question. | Trends Mol Med | 2017 | https://conductscience.org/library/papers/28427863 | PubMed |
| 2 | 16484333 | Biomarkers of oxidative damage in human disease. | Clin Chem | 2006 | https://conductscience.org/library/papers/16484333 | PubMed |
| 3 | 25402766 | Peroxiredoxin-2 and STAT3 form a redox relay for H2O2 signaling. | Nat Chem Biol | 2015 | https://conductscience.org/library/papers/25402766 | PubMed |
| 4 | 28358012 | Suppression of FOXM1 Transcriptional Activities via a Single-Stranded DNA Aptamer Generated by SELEX. | Sci Rep | 2017 | https://conductscience.org/library/papers/28358012 | PubMed |
| 5 | 31544965 | Prdx4 limits caspase-1 activation and restricts inflammasome-mediated signaling by extracellular vesicles. | EMBO J | 2019 | https://conductscience.org/library/papers/31544965 | PubMed |
| 6 | 37977211 | Dual role of PRDX1 in redox-regulation and tumorigenesis: Past and future. | Free Radic Biol Med | 2024 | https://conductscience.org/library/papers/37977211 | PubMed |
| 7 | 12832285 | Oxidative DNA damage: mechanisms, mutation, and disease. | FASEB J | 2003 | https://conductscience.org/library/papers/12832285 | PubMed |
| 8 | 21062979 | Induction of human epithelial stem/progenitor expansion by FOXM1. | Cancer Res | 2010 | https://conductscience.org/library/papers/21062979 | PubMed |
| 9 | 23198756 | Post-translational control of protein function by disulfide bond cleavage. | Antioxid Redox Signal | 2013 | https://conductscience.org/library/papers/23198756 | PubMed |
| 10 | 32231263 | Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. | Nat Rev Mol Cell Biol | 2020 | https://conductscience.org/library/papers/32231263 | PubMed |
| 11 | 18501712 | A novel function of peroxiredoxin 1 (Prx-1) in apoptosis signal-regulating kinase 1 (ASK1)-mediated signaling pathway. | FEBS Lett | 2008 | https://conductscience.org/library/papers/18501712 | PubMed |
| 12 | 34740322 | NOX4-derived ROS-induced overexpression of FOXM1 regulates aerobic glycolysis in glioblastoma. | BMC Cancer | 2021 | https://conductscience.org/library/papers/34740322 | PubMed |
| 13 | 10759556 | Removal of oxygen free-radical-induced 5',8-purine cyclodeoxynucleosides from DNA by the nucleotide excision-repair pathway in human cells. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/10759556 | PubMed |
| 14 | 22024885 | Direct observation of disulfide isomerization in a single protein. | Nat Chem | 2011 | https://conductscience.org/library/papers/22024885 | PubMed |
| 15 | 10959836 | A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. | Curr Biol | 2000 | https://conductscience.org/library/papers/10959836 | PubMed |
| 16 | 15917183 | Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. | Free Radic Biol Med | 2005 | https://conductscience.org/library/papers/15917183 | PubMed |
| 17 | 19696738 | FoxM1, a critical regulator of oxidative stress during oncogenesis. | EMBO J | 2009 | https://conductscience.org/library/papers/19696738 | PubMed |
| 18 | 11916965 | Reversible inactivation of the tumor suppressor PTEN by H2O2. | J Biol Chem | 2002 | https://conductscience.org/library/papers/11916965 | PubMed |
| 19 | 35583996 | Transcriptional Repression by FoxM1 Suppresses Tumor Differentiation and Promotes Metastasis of Breast Cancer. | Cancer Res | 2022 | https://conductscience.org/library/papers/35583996 | PubMed |
| 20 | 12714747 | Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. | Science | 2003 | https://conductscience.org/library/papers/12714747 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FOXM1 | 2305 | PubTator's text mining | https://conductscience.org/library/genes/2305 | NCBI Gene |
| PRDX1 | 5052 | PubTator's text mining | https://conductscience.org/library/genes/5052 | NCBI Gene |
| XRCC1 | 7515 | PubTator's text mining | https://conductscience.org/library/genes/7515 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41244121
GET https://conductscience.org/api/papers/v1/41244121/references?page=2